Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism

Simple item page
dc.contributor.authorDake, Michael D.
dc.contributor.authorMurphy, Timothy P.
dc.contributor.authorKramer, Albrecht H.
dc.contributor.authorDarcy, Michael D.
dc.contributor.authorSewall, Luke E.
dc.contributor.authorCuri, Michael A.
dc.contributor.authorJohnson, Matthew S.
dc.contributor.authorArena, Frank
dc.contributor.authorSwischuk, James L.
dc.contributor.authorAnsel, Gary M.
dc.contributor.authorSilver, Mitchell J.
dc.contributor.authorSaddekni, Souheil
dc.contributor.authorBrower, Jayson S.
dc.contributor.authorMendes, Robert
dc.contributor.authorFeezor, Robert
dc.contributor.authorKalva, Sanjeeva
dc.contributor.authorKies, Darren
dc.contributor.authorBosiers, Marc
dc.contributor.authorZiegler, Werner
dc.contributor.authorFarber, Mark
dc.contributor.authorPaolini, David
dc.contributor.authorSpillane, Robert
dc.contributor.authorJones, Steven
dc.contributor.authorPeeters, Patrick
dc.contributor.authorSENTRY Trial Investigators
dc.date.accessioned2024-01-10T13:48:24Z
dc.date.available2024-01-10T13:48:24Z
dc.date.issued2020
dc.description.abstractPurpose: To report final 2-year outcomes with the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).
dc.description.abstractMaterials and Methods: In a prospective multicenter trial, the Sentry filter was implanted in 129 patients with documented deep vein thrombosis (DVT) and/or PE (67.5%) or who were at temporary risk of developing DVT/PE (32.6%). Patients were monitored and bioconversion status ascertained by radiography, computed tomography (CT), and CT venography through 2 years.
dc.description.abstractResults: The composite primary 6-month endpoint of clinical success was achieved in 97.4% (111/114) of patients. The rate of new symptomatic PE was 0% (n = 126) through 1 year and 2.4% (n = 85) through the second year of follow-up, with 2 new nonfatal cases at 581 and 624 days that were adjudicated as not related to the procedure or device. Two patients (1.6%) developed symptomatic caval thrombosis during the first month and underwent successful interventions without recurrence. No other filter-related symptomatic complications occurred through 2 years. There was no filter tilting, migration, embolization, fracture, or caval perforation and no filter-related deaths through 2 years. Filter bioconversion was successful for 95.7% (110/115) of patients at 6 months, 96.4% (106/110) of patients at 12 months, and 96.5% (82/85) of patients at 24 months. Through 24 months of follow-up, there was no evidence of late-stage IVC obstruction or thrombosis after filter bioconversion or of thrombogenicity associated with retracted filter arms.
dc.description.abstractConclusions: The Sentry IVC filter provided safe and effective protection against PE, with a high rate of intended bioconversion and a low rate of device-related complications, through 2 years of follow-up.
dc.description.funderBTG Vascular (Bothell, Washington)
dc.fechaingreso.objetodigital01-04-2024
dc.format.extent10 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.jvir.2019.08.036
dc.identifier.eissn1535-7732
dc.identifier.issn1051-0443
dc.identifier.pubmedidMEDLINE:31711748
dc.identifier.urihttps://doi.org/10.1016/j.jvir.2019.08.036
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/79362
dc.identifier.wosidWOS:000514221100005
dc.information.autorucMedicina;Kramer Schumacher Albrecht Hel;S/I;98256
dc.issue.numero2
dc.language.isoen
dc.nota.accesocontenido completo
dc.pagina.final230
dc.pagina.inicio221
dc.publisherELSEVIER SCIENCE INC
dc.revistaJOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
dc.rightsacceso abierto
dc.subjectDENALI TRIAL
dc.subjectCOMPLICATIONS
dc.subjectMULTICENTER
dc.subjectPLACEMENT
dc.subjectTRAUMA
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleFinal Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism
dc.typeartículo
dc.volumen31
sipa.codpersvinculados98256
sipa.indexWOS
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2024-04-01. Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas